Aethlon Medical, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $1.9M
- Price
- $2.73
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.11%
- Volume
- 37.5K
About
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.
Quick stats
Shares outstanding526.7K
Computed float637.6K
Float / shares121.1%
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000882291
AI Summary
AI-generated1/17
minorneutralother
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
Aethlon Medical is scheduled to present at the 95th Emerging Growth Conference on Day 1, August 19, 2026.
The management presentation is set for 2:55 PM to 3:05 PM Eastern Time.
Keynote speakers will include CEO and CFO Jim Frakes and Chief Medical Officer Steven LaRosa.